Antiemetic Prophylaxis with Fosaprepitant and 5-HT(3)-Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation

BACKGROUND: High-dose myeloablative conditioning prior to autologous hematopoietic stem cell transplantation (autoHSCT) in pediatric patients is usually highly emetogenic. The antiemetic neurokinin-1 receptor antagonist fosaprepitant was safe and effective in children receiving highly emetogenic che...

Full description

Saved in:
Bibliographic Details
Published in:Drug Des Devel Ther
Main Authors: Cabanillas Stanchi, Karin Melanie, Willier, Semjon, Vek, Julia, Schlegel, Patrick, Queudeville, Manon, Rieflin, Nora, Klaus, Veronika, Gansel, Melanie, Rupprecht, Joachim Vincent, Flaadt, Tim, Binder, Vera, Feuchtinger, Tobias, Lang, Peter, Handgretinger, Rupert, Döring, Michaela
Format: Artigo
Language:Inglês
Published: Dove 2020
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7524181/
https://ncbi.nlm.nih.gov/pubmed/33061297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S260887
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items